Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

WAKAYAMA MEDICAL UNIVERSITY

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: Private

Established: 1945-01-01

Employees: -

Market Cap: -

Website: http://www.wakayama-med.ac.jp/intro/index.html

Clinical Trials

Isolation Procedure vs. Conventional Procedure During Distal Pancreatectosplenectomy for Pancreatic Cancer

Not Applicable

Recruiting

Conditions: Resectable Pancreatic Body/Tail Carcinoma

First Posted Date: 2020-10-23

Last Posted Date: 2020-10-23

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 100

Registration Number: NCT04600063

Locations: 🇯🇵
Kobe University, Kobe, Hyogo, Japan
🇯🇵
Nara Medical University, Kashihara, Nara, Japan
🇯🇵
Kinki University, Sayama, Osaka, Japan

and more 7 locations

Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer

Phase 3

Conditions: Pancreatic Ductal Adenocarcinoma
Mesenteric Approach
Pancreaticoduodenectomy

First Posted Date: 2017-10-23

Last Posted Date: 2017-10-24

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 354

Registration Number: NCT03317886

Locations: 🇯🇵
Kyusyu University, Fukuoka, Japan
🇯🇵
Kansai Medical University, Hirakata, Japan
🇯🇵
Hiroshima University, Hiroshima, Japan

and more 12 locations

Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer

Phase 2

Conditions: Small Cell Lung Cancer Extensive Stage

Interventions: Drug: Pembrolizumab plus amurubicin

First Posted Date: 2017-08-17

Last Posted Date: 2020-05-19

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 25

Registration Number: NCT03253068

Locations: 🇯🇵
Wakayama Medical University, Wakayama, Japan

Study of NAC of GA Therapy for Patients With BRPC

Phase 2

Conditions: Pancreatic Ductal Adenocarcinoma

Interventions: Drug: Neoadjuvant chemotherapy of gemcitabine plus nab-paclitaxel

First Posted Date: 2016-10-06

Last Posted Date: 2019-10-03

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 60

Registration Number: NCT02926183

Locations: 🇯🇵
Hirosaki University, Hirosaki, Aomori, Japan
🇯🇵
Kobe University, Kobe, Hyogo, Japan
🇯🇵
Hyogo College of Medicine, Nishinomiya, Hyogo, Japan

and more 15 locations

Combined Resection vs. Separated Resection After Mobilization of Splenic Vein During Distal Pancreatectomy

Phase 3

Conditions: Pancreatic Neoplasms

First Posted Date: 2016-08-18

Last Posted Date: 2016-08-18

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 304

Registration Number: NCT02871804

Locations: 🇯🇵
Wakayama Medical University, Wakayama, Japan

The Prediction Using Diffusion MRI of the Response Evaluation in BRPC in NAT.

Completed

Conditions: Pancreatic Cancer

First Posted Date: 2016-05-19

Last Posted Date: 2020-05-20

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 28

Registration Number: NCT02777463

Locations: 🇯🇵
Wakayama Medical University, Wakayama, Wakayama Prefecture, Japan

Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer.

Phase 1

Conditions: Pancreatic Cancer

Interventions: Drug: NAC-GEMABR

First Posted Date: 2015-07-23

Last Posted Date: 2016-05-12

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 10

Registration Number: NCT02506803

Locations: 🇯🇵
Wakayama Medical University, Wakayama, Japan

Predictive Risk Factors for Pancreatic Fistula Grade C After Pancreaticoduodenectomy

Conditions: Disease of Pancreatic Head or Periampullary Lesions to Require Pancreaticoduodenectomy

First Posted Date: 2014-12-23

Last Posted Date: 2014-12-23

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 3000

Registration Number: NCT02322424

Locations: 🇨🇳
Chang Gun Memorial Hospital, Linkou, Taiwan

A Prospective, Multi-center Trial for Reinforced Staple During Distal Pancreatectomy

Phase 2

Completed

Conditions: Pancreatic Neoplasms

First Posted Date: 2014-10-21

Last Posted Date: 2016-07-21

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 120

Registration Number: NCT02270554

Locations: 🇯🇵
Kansai Rosai Hospital, Amagasaki, Hyogo, Japan
🇯🇵
Kansai Medical University, Hirakata, Osaka, Japan
🇯🇵
Hiroshima University, Hiroshima, Hiroshima, Japan

and more 8 locations

Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot Study

Phase 1

Completed

Conditions: Patients With Borderline Resectable Pancreatic Cancer

Interventions: Drug: FIRINOX

First Posted Date: 2014-05-28

Last Posted Date: 2019-10-07

Lead Sponsor: Wakayama Medical University

Target Recruit Count: 10

Registration Number: NCT02148549

Locations: 🇯🇵
Nagoya University, Nagoya, Aichi, Japan
🇯🇵
Kobe University, Kobe, Hyogo, Japan
🇯🇵
Nara Prefectual Medical University, Kashihara, Nara, Japan

and more 6 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy